微创泌尿外科杂志
微創泌尿外科雜誌
미창비뇨외과잡지
JOURNAL OF MINIMALLY INVASIVE UROLOGY
2014年
5期
268-270
,共3页
李淦洪%杨俊%李乾伟%王亚东%黄美红
李淦洪%楊俊%李乾偉%王亞東%黃美紅
리감홍%양준%리건위%왕아동%황미홍
经尿道膀胱肿瘤电切术%膀胱癌%反复性出血
經尿道膀胱腫瘤電切術%膀胱癌%反複性齣血
경뇨도방광종류전절술%방광암%반복성출혈
transurethral resection of bladder tumor%bladder translational cell carcinoma recurrent bleeding
目的::评价经尿道膀胱肿瘤电切术(transurethral resection of bladder tumor,TURBT)在治疗高龄膀胱癌合并反复性出血中的疗效及安全性.方法:2003年5月~2013年5月共收治高龄膀胱癌合并反复性出血患者62例,行TURBT治疗.结果:62例患者手术均顺利完成,无术中死亡,无术中输血;术后常规用丝裂霉素40 mg+0.9%生理盐水40 ml 进行膀胱灌注化疗.术后采用电话随访,随访时间为6~60个月,平均32个月;均能达到良好止血效果,患者生活质量明显改善,5年生存率为79.0%.结论:TURBT处理高龄膀胱癌合并反复性出血止血效果达100%,安全系数高,术后配合丝裂霉素化疗,达到治疗及改善生存质量的目的.
目的::評價經尿道膀胱腫瘤電切術(transurethral resection of bladder tumor,TURBT)在治療高齡膀胱癌閤併反複性齣血中的療效及安全性.方法:2003年5月~2013年5月共收治高齡膀胱癌閤併反複性齣血患者62例,行TURBT治療.結果:62例患者手術均順利完成,無術中死亡,無術中輸血;術後常規用絲裂黴素40 mg+0.9%生理鹽水40 ml 進行膀胱灌註化療.術後採用電話隨訪,隨訪時間為6~60箇月,平均32箇月;均能達到良好止血效果,患者生活質量明顯改善,5年生存率為79.0%.結論:TURBT處理高齡膀胱癌閤併反複性齣血止血效果達100%,安全繫數高,術後配閤絲裂黴素化療,達到治療及改善生存質量的目的.
목적::평개경뇨도방광종류전절술(transurethral resection of bladder tumor,TURBT)재치료고령방광암합병반복성출혈중적료효급안전성.방법:2003년5월~2013년5월공수치고령방광암합병반복성출혈환자62례,행TURBT치료.결과:62례환자수술균순리완성,무술중사망,무술중수혈;술후상규용사렬매소40 mg+0.9%생리염수40 ml 진행방광관주화료.술후채용전화수방,수방시간위6~60개월,평균32개월;균능체도량호지혈효과,환자생활질량명현개선,5년생존솔위79.0%.결론:TURBT처리고령방광암합병반복성출혈지혈효과체100%,안전계수고,술후배합사렬매소화료,체도치료급개선생존질량적목적.
Objective:The aim of this study was to evaluate the efficacy and security of transurethral resection of bladder tumor (TURBT)for bladder carcinoma with recurrent bleeding in elderly patients.Methods:62-patient were selected and treated with TURBT between May 2003 and May 2012,and all people were diagnosed as bladder transi-tional cell carcinoma by pathology after operation.Results:All people were operated a successful TURBT,without intraoperative blood transfusion or intraoperative death.Conventional postoperatively with mitomycin 40 mg was di-luted by 40 mL saline water for bladder perfusion chemotherapy.All people postoperatively information were collect-ed by telephone,and the follow-up time from 6 to 60 months,the average time was 32 months.62-patient achieved well hemostasis and significantly improved the quality of the life.Moreover,the 5-year survival rate was arrived 79.0% after TURBT.Conclusions:The effect of TURBT treatment of the bladder carcinoma patients with recurrent bleeding reached at 100%,and improved the quality of the life for therapeutic purposes.